 |
Video: What is a Stock Split?
|
 |
Aethlon Medical, Inc. is a medical therapeutic company which develop the Hemopurifier, an immunotherapeutic device aimed at treating cancer, life-threatening viral infections, and aiding in organ transplantation. Pre-clinical studies show it can remove harmful exosomes from biological fluids using lectin-based technology. The FDA has designated it as a Breakthrough Device for advanced or metastatic cancer unresponsive to standard therapies and for treating life-threatening viruses not addressed by approved therapies, with an open Investigational Device Exemption. According to our AEMD split history records, Aethlon Medical has had 2 splits. | |
 |

Aethlon Medical (AEMD) has 2 splits in our AEMD split history database. The first split for AEMD took place on October 15, 2019. This was a 1 for 15 reverse split, meaning for each 15 shares of AEMD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. AEMD's second split took place on October 05, 2023. This was a 1 for 10 reverse split, meaning for each 10 shares of AEMD owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 6.66666666666667 share position following the split.
When a company such as Aethlon Medical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AEMD split history from start to finish, an original position size of 1000 shares would have turned into 6.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aethlon Medical shares, starting with a $10,000 purchase of AEMD, presented on a split-history-adjusted basis factoring in the complete AEMD split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/01/2015 |
|
End date: |
04/29/2025 |
|
Start price/share: |
$1,276.50 |
|
End price/share: |
$0.41 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.97% |
|
Average Annual Total Return: |
-55.25% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.21 |
|
Years: |
10.00 |
|
|
 |
Date |
Ratio |
10/15/2019 | 1 for 15 | 10/05/2023 | 1 for 10 |
|
 |